Back
Vir Biotechnology Quote, Financials, Valuation and Earnings
Sponsored
VIR
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
17
VIR
Vir Biotechnology
Last Price:
7.92
Seasonality Move:
6.96%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Vir Biotechnology Price Quote
$7.92
+0.11 (+1.41%)
(Updated: September 19, 2024 at 6:55 PM ET)
Vir Biotechnology Key Stats
Sell
17
Vir Biotechnology (VIR)
is a Sell
Day range:
$7.79 - $8.13
52-week range:
$7.41 - $13.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.30
P/B ratio:
0.74%
Volume:
764.9K
Avg. volume:
694.2K
1-year change:
-18.9%
Market cap:
$1.1B
Revenue:
$39.5M
EPS:
$-3.58
How Much Does Vir Biotechnology Make?
-
How Much Are Vir Biotechnology's Sales Annually?
VIR Revenues are $39.5M -
How Much Profit Does Vir Biotechnology's Make A Year?
VIR net income is -$615.1M
Is Vir Biotechnology Growing As A Company?
Data Unavailable
Vir Biotechnology Stock Price Performance
-
Did Vir Biotechnology Stock Go Up Last Month?
Vir Biotechnology share price went down by -9.4% last month -
Did VIR's Share Price Rise Over The Last Year?
VIR share price fell by -18.9% over the past 1 year
What Is Vir Biotechnology 52-Week High & Low?
-
What Is Vir Biotechnology’s 52-Week High Share Price?
Vir Biotechnology has traded as high as $13.09 over the past 52 weeks -
What Is Vir Biotechnology’s 52-Week Low Share Price?
Vir Biotechnology has traded as low as $7.41 over the past 52 weeks
Vir Biotechnology Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Vir Biotechnology?
-
How Much Debt Does Vir Biotechnology Have?
Total long term debt quarterly is $0 -
How Much Cash Does Vir Biotechnology Have?
Cash and short term investments quarterly total is $1.2B -
What Is Vir Biotechnology’s Book Value Per Share?
Book value per share is 10.50
Is Vir Biotechnology Cash Flow Positive?
-
What Is VIR Cash Flow From Operations?
Cash flow from operations (TTM) is -$451M -
What Is Vir Biotechnology’s Cash Flow From Financing?
Cash flow from financing (TTM) is $5.1M -
What Is Vir Biotechnology’s Cash Flow From Investing?
Cash flow from investing (TTM) is $76.3M
Vir Biotechnology Return On Invested Capital
-
Is Management Doing A Good Job?
VIR return on invested capital is -29.98% -
What Is Vir Biotechnology Return On Assets?
ROA measures how assets are converting to revenues and is -24.97% -
What Is VIR Return On Equity?
ROE is a measure of profitability and is -29.98%
Vir Biotechnology Earnings Date & Stock Price
-
What Is Vir Biotechnology's Stock Price Today?
A single share of VIR can be purchased today for 7.81 -
What Is Vir Biotechnology’s Stock Symbol?
Vir Biotechnology trades on the nasdaq under the ticker symbol: VIR -
When Is Vir Biotechnology’s Next Earnings Date?
The next quarterly earnings date for Vir Biotechnology is scheduled on November 1, 2024 -
When Is VIR's next ex-dividend date?
Vir Biotechnology's next ex-dividend date is September 20, 2024 -
How To Buy Vir Biotechnology Stock?
You can buy Vir Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Vir Biotechnology Competitors
-
Who Are Vir Biotechnology's Competitors?
Below is a list of companies who compete with Vir Biotechnology or are related in some way:
Vir Biotechnology Dividend Yield
-
What Is VIR Dividend Yield?
Vir Biotechnology’s dividend yield currently is 0% -
What Is Vir Biotechnology’s Payout Ratio?
Vir Biotechnology’s payout ratio is 0% -
When Did Vir Biotechnology Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is Vir Biotechnology’s Dividend Per Share?
Vir Biotechnology pays a dividend of $0.00 per share
Vir Biotechnology Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -14.05% |
Revenue: | 0% | -58.98% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 3 |
Sell Recommendations: | 0 |
Price Target: | 31.25 |
Upside from Last Price: | 300.13% |